{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:31:22Z","timestamp":1751355082614,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Accion Transversal del Cancer"},{"name":"Instituto de Salud Carlos III-FEDER","award":["PI08\/1770","PI08\/0533","PI08\/1359","PI09\/00773","PI09\/01286","PI09\/01903","PI09\/02078","PI09\/01662","PI11\/01403","PI11\/01889-FEDER","PI11\/00226","PI11\/01810","PI11\/02213","PI12\/00488","PI12\/00265","PI12\/01270","PI12\/00715","PI12\/00150","PI14\/01219","PI14\/0613","PI15\/00069","PI15\/01032","PI15\/00914"],"award-info":[{"award-number":["PI08\/1770","PI08\/0533","PI08\/1359","PI09\/00773","PI09\/01286","PI09\/01903","PI09\/02078","PI09\/01662","PI11\/01403","PI11\/01889-FEDER","PI11\/00226","PI11\/01810","PI11\/02213","PI12\/00488","PI12\/00265","PI12\/01270","PI12\/00715","PI12\/00150","PI14\/01219","PI14\/0613","PI15\/00069","PI15\/01032","PI15\/00914"]}]},{"name":"Fundaci\u00f3n Marqu\u00e9s de Valdecilla","award":["API 10\/09"],"award-info":[{"award-number":["API 10\/09"]}]},{"name":"ICGC International Cancer Genome Consortium CLL"},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n del C\u00e1ncer (RTICC) del ISCIII","award":["RD12\/0036\/0036"],"award-info":[{"award-number":["RD12\/0036\/0036"]}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"crossref","award":["LE22A10-2"],"award-info":[{"award-number":["LE22A10-2"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Consejer\u00eda de Salud of the Junta de Andaluc\u00eda","award":["2009-S0143"],"award-info":[{"award-number":["2009-S0143"]}]},{"name":"Conselleria de Sanitat of the Generalitat Valenciana","award":["AP_061\/10"],"award-info":[{"award-number":["AP_061\/10"]}]},{"name":"Recercaixa","award":["2010ACUP 00310"],"award-info":[{"award-number":["2010ACUP 00310"]}]},{"name":"Regional Government of the Basque Country"},{"name":"Consejer\u00eda de Sanidad de la Regi\u00f3n de Murcia"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FOOD-CT-2006-036224-HIWATE"],"award-info":[{"award-number":["FOOD-CT-2006-036224-HIWATE"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Association Against Cancer (AECC) Scientific Foundation"},{"name":"Catalan Government DURSI","award":["2014SGR647"],"award-info":[{"award-number":["2014SGR647"]}]},{"name":"Fundaci\u00f3n Caja de Ahorros de Asturias"},{"DOI":"10.13039\/501100006382","name":"University of Oviedo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ypmed.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T09:18:05Z","timestamp":1485422285000},"page":"178-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6127-0077","authenticated-orcid":false,"given":"Trinidad","family":"Dierssen-Sotos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"G\u00f3mez-Acebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Palazuelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rodriguez-Moranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"P\u00e9rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Pedro","family":"Fern\u00e1ndez Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Amiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Barricarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Mir\u00f3n-Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adonina","family":"Tardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Capelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Peiro P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa \u00c1ngeles","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Casta\u00f1\u00f3n L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irune","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Moreno-Iribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Olmedo-Requena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Casta\u00f1o-Vinyals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Aragon\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis","family":"Kogevinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ypmed.2017.01.011_bb0005","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ypmed.2017.01.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050893","article-title":"Long-term use of angiotensin receptor blockers and the risk of cancer","volume":"7","author":"Azoulay","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gut.2009.190900","article-title":"Effect of statin therapy on colorectal cancer","volume":"59","author":"Bardou","year":"2010","journal-title":"Gut"},{"issue":"344","key":"10.1016\/j.ypmed.2017.01.011_bb0020","article-title":"Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database","volume":"24","author":"Bhaskaran","year":"2012","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ypmed.2017.01.011_bb0025","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1158\/1055-9965.EPI-08-0095","article-title":"Cardiovascular medication use and risk for colorectal cancer","volume":"17","author":"Boudreau","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ypmed.2017.01.011_bb0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gaceta.2014.12.003","article-title":"Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design","volume":"29","author":"Casta\u00f1o-Vinyals","year":"2015","journal-title":"Gac. Sanit."},{"issue":"10","key":"10.1016\/j.ypmed.2017.01.011_bb0035","first-page":"2547","article-title":"Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992\u20131997","volume":"15; 92","author":"Cheng","year":"2001","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ypmed.2017.01.011_bb0040","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/ijc.25234","article-title":"Deficiency or blockade of angiotensin II type 2-receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis","volume":"127","author":"Clere","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ypmed.2017.01.011_bb0050","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10552-015-0617-1","article-title":"Angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis","volume":"26","author":"Dai","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.ypmed.2017.01.011_bb0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijcard.2014.11.031","article-title":"A review of clinical studies on angiotensin II receptor blockers and risk of cancer","volume":"177","author":"D\u00e9zsi","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ypmed.2017.01.011_bb0060","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"9573","key":"10.1016\/j.ypmed.2017.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"British doctors aspirin trial and the UK-TIA aspirin trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ypmed.2017.01.011_bb0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02234301","article-title":"Predictors of proximal vs. distal colorectal cancers","volume":"44","author":"Gonzalez","year":"2001","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11906-002-0054-x","article-title":"Microvascular angiogenesis and the renin-angiotensin system","volume":"4","author":"Greene","year":"2002","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0085","first-page":"1","article-title":"Long-term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case control study","volume":"73","author":"Hallas","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-002608","article-title":"A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer","volume":"3","author":"Jess","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ypmed.2017.01.011_bb0100","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MCG.0b013e3181ea1044","article-title":"Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps","volume":"45","author":"Kedika","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.aje.a117078","article-title":"Comparing self-reported and physician-reported medical history","volume":"139","author":"Kehoe","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008741321384","article-title":"Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in the Netherlands","volume":"21","author":"Klungel","year":"1999","journal-title":"Pharm. World Sci."},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.011_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2011.05.115","article-title":"Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL\/KsJ-db\/db obese mice","volume":"410","author":"Kubota","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ypmed.2017.01.011_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1631\/jzus.B0820273","article-title":"Colorectal cancer, one entity or three","volume":"10","author":"Li","year":"2009","journal-title":"J. Zhejiang Univ. Sci. B."},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.011_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00001622-200101000-00013","article-title":"Different mechanisms in the tumorigenesis of proximal and distal colon cancers","volume":"13","author":"Lindblom","year":"2001","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0130","article-title":"Obesity and risk of colorectal cancer: a systematic review of prospective studies","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ypmed.2017.01.011_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt374","article-title":"Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk","volume":"106","author":"Makar","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.011_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jch.12225","article-title":"ACE inhibitors and ARBs: do they reduce the risk of cancer?","volume":"16","author":"Man","year":"2014","journal-title":"J. Clin. Hypertens. (Greenwich)."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/bjc.2013.292","article-title":"The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer-screening programme","volume":"109","author":"Mansouri","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.ypmed.2017.01.011_bb0150","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ijc.25481","article-title":"Sex disparities in colorectal cancer incidence by anatomic subsite, race and age","volume":"128","author":"Murphy","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ajg.2012.180","article-title":"Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis","volume":"107","author":"Okabayashi","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ypmed.2017.01.011_bb0160","first-page":"R205","article-title":"Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis","volume":"305","author":"Okwan-Duodu","year":"2013","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"22","key":"10.1016\/j.ypmed.2017.01.011_bb0165","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2146\/ajhp100570","article-title":"Risk of cancer associated with the use of angiotensin II-receptor blockers","volume":"68","author":"Olin","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.ypmed.2017.01.011_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/MEG.0b013e328335ef50","article-title":"Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: implications for carcinogenesis and colorectal cancer epidemiology","volume":"22","author":"Papaxoinis","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0175","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.107.106922","article-title":"Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked","volume":"51","author":"Sartori-Valinotti","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/HCO.0b013e328353bc4f","article-title":"Which, if any, antihypertensive agents cause cancer?","volume":"27","author":"Singh","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0190","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/ijc.25258","article-title":"Colon cancer in Iceland a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age","volume":"127","author":"Snaebjornsson","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ypmed.2017.01.011_bb0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jnci\/djt438","article-title":"Antihypertension and colorectal cancer prevention: getting two birds with one stone?","volume":"106","author":"Song","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.011_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3945\/ajcn.113.066530","article-title":"Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study","volume":"99","author":"Steins Bisschop","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0205","first-page":"R1220","article-title":"Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition","volume":"294","author":"Sullivan","year":"2008","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"14","key":"10.1016\/j.ypmed.2017.01.011_bb0210","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1096\/fj.03-0129com","article-title":"Differential regulation of in vivo angiogenesis by angiotensin II receptors","volume":"17","author":"Walther","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ypmed.2017.01.011_bb0220","first-page":"741","article-title":"Critical review of cancer risk associated with angiotensin receptor blocker therapy","volume":"7","author":"Wuerzner","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.ypmed.2017.01.011_bb0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/gutjnl-2012-302014","article-title":"Colorectal cancer: a tale of two sides, or a continuum?","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00432-004-0582-7","article-title":"Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells","volume":"130","author":"Yasumatsu","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.ypmed.2017.01.011_bb0235","doi-asserted-by":"crossref","first-page":"E1073","DOI":"10.1503\/cmaj.101497","article-title":"Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies","volume":"183","author":"Yoon","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ypmed.2017.01.011_bb0240","first-page":"1073","article-title":"The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor","volume":"7","author":"Yoshiji","year":"2001","journal-title":"Clin. Cancer Res."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T02:44:52Z","timestamp":1655606692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174351730035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":47,"alternative-id":["S009174351730035X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.01.011","relation":{},"ISSN":["0091-7435"],"issn-type":[{"type":"print","value":"0091-7435"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}